T&R Biofab is coming from South Korea and they are very well established in the world of bioprinting artificial organs with their unique 3D bioprinting technology.
- Expected to be an innovative alternative to hair loss treatment with characteristics similar to living hair follicles
T&R Biofab (246710), a regenerative medicine company, has completed domestic patent registration for its 'hair follicle spheroid (3D cultured cell aggregate)' technology for hair loss treatment.
This patented technology relates to 'a method for producing asymmetric hair follicle spheroids and asymmetric hair follicle spheroids produced by this method', which uses multiple bio-inks containing outer root sheath cells, dermal papilla cells, and inner hair root sheath cells to produce hair. This is a technology to produce hair follicle spheroids that have the effect of growing in a specific direction.
Hair is composed of keratin protein and grows from hair follicles in the dermis. Scalp hair follicles are composed of dermal papilla cells, keratinocytes, inner hair sheath cells, outer root sheath cells, and melanocytes. Among these, dermal papilla cells are known to be the basis for hair follicle development and are closely related to hair growth.
Currently, technologies for culturing hair follicle spheroids in vitro are being studied for hair loss treatment or hair follicle cell growth research. However, existing technologies have limitations such as difficulty in co-culturing multiple cells, considerable production time, and variation in the size of each cell spheroid. had a In addition, while hair follicles grown in the body naturally provide direction to the hair, it has been pointed out as a problem that it is difficult to give direction to the hair in hair follicle spheroids produced in vitro.
The asymmetric hair follicle spheroid developed by T&R Biofab is designed to produce hair by filling and printing multiple bioinks containing outer root sheath cells, dermal papilla cells, and inner hair root sheath cells into partition members having asymmetrically partitioned areas. This provides the effect of growing in a specific direction. In addition, manufacturing is simple and fast using 3D bioprinting, and each individual object has uniform quality.
A company official said, “We expect to be able to present an innovative alternative to hair loss treatment through the development of hair follicle spheroids that have characteristics similar to biological hair follicles where hair develops and grows,” adding, “We will further develop related technologies targeting the rapidly growing hair loss treatment market.” “We will focus on upgrading and commercializing it,” he emphasized.
Check their official press release: http://tnrbiofab.com/notice/press.php?admin_mode=read&no=279
T&R Biofab recently transplanted first artificial 3D bioprinted trachea into human:
www.3dnatives.com
Video presentantion:
LinkedIn profile: https://kr.linkedin.com/company/tnrbiofab
| T&R Biofab patents 3D printing-based hair follicle spheroid manufacturing technology |
|---|
- Expected to be an innovative alternative to hair loss treatment with characteristics similar to living hair follicles
T&R Biofab (246710), a regenerative medicine company, has completed domestic patent registration for its 'hair follicle spheroid (3D cultured cell aggregate)' technology for hair loss treatment.
This patented technology relates to 'a method for producing asymmetric hair follicle spheroids and asymmetric hair follicle spheroids produced by this method', which uses multiple bio-inks containing outer root sheath cells, dermal papilla cells, and inner hair root sheath cells to produce hair. This is a technology to produce hair follicle spheroids that have the effect of growing in a specific direction.
Hair is composed of keratin protein and grows from hair follicles in the dermis. Scalp hair follicles are composed of dermal papilla cells, keratinocytes, inner hair sheath cells, outer root sheath cells, and melanocytes. Among these, dermal papilla cells are known to be the basis for hair follicle development and are closely related to hair growth.
Currently, technologies for culturing hair follicle spheroids in vitro are being studied for hair loss treatment or hair follicle cell growth research. However, existing technologies have limitations such as difficulty in co-culturing multiple cells, considerable production time, and variation in the size of each cell spheroid. had a In addition, while hair follicles grown in the body naturally provide direction to the hair, it has been pointed out as a problem that it is difficult to give direction to the hair in hair follicle spheroids produced in vitro.
The asymmetric hair follicle spheroid developed by T&R Biofab is designed to produce hair by filling and printing multiple bioinks containing outer root sheath cells, dermal papilla cells, and inner hair root sheath cells into partition members having asymmetrically partitioned areas. This provides the effect of growing in a specific direction. In addition, manufacturing is simple and fast using 3D bioprinting, and each individual object has uniform quality.
A company official said, “We expect to be able to present an innovative alternative to hair loss treatment through the development of hair follicle spheroids that have characteristics similar to biological hair follicles where hair develops and grows,” adding, “We will further develop related technologies targeting the rapidly growing hair loss treatment market.” “We will focus on upgrading and commercializing it,” he emphasized.
Check their official press release: http://tnrbiofab.com/notice/press.php?admin_mode=read&no=279
T&R Biofab recently transplanted first artificial 3D bioprinted trachea into human:
World's First 3D Printed Trachea Successfully Transplanted in South Korea - 3Dnatives
The world's first 3D printed trachea transplant at Seoul St. Mary's Hospital has demonstrated the potential of AM in regenerative medicine.
www.3dnatives.com
Video presentantion:
LinkedIn profile: https://kr.linkedin.com/company/tnrbiofab
